Back

Head-to-head comparison of inclisiran vs bempedoic acid for LDL C lowering in patients with high and very high cardiovascular risk: Results from the phase 4 VICTORION-CHALLENGE trial

31 August 2026 (08:15 - 08:30)
Organised by: Logo
Congress Presentation Part of: Beyond statins: the next wave of lipid-lowering therapies Drug therapy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ingo Hilgendorf

Charité - University Medicine Berlin, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Oral HRS-5346, a novel small molecule lipoprotein(a) inhibitor, in adults at high cardiovascular risk with elevated lipoprotein(a): a phase 2, randomized, double-blind study
Doctor D. Zhu (Beijing, CN)
Slides Video
Presentation thumbnail
Protocol-based early intensive lipid management in patients with acute coronary syndrome (BRIDGE): A multicenter prospective cluster-randomized controlled trial
Doctor K. Oyama (Sendai, JP)
Slides Video
Presentation thumbnail
A phase 3 clinical trial to evaluate the efficacy and safety of vsa003 injection in chinese adolescents and adults with homozygous familial hypercholesterolaemia (hofh)
Doctor Z. Tian (Beijing, CN)
Slides Video
Presentation thumbnail
Effects of Evolocumab on Fatal Outcomes in Patients Without a Prior Myocardial Infarction or Stroke : Pre-specified Analysis of the VESALIUS-CV Trial
Doctor R. Giugliano (Boston, US)
Slides Video
Presentation thumbnail
Effect on Oxidized Phospholipids of Lepodisiran, an Extended Duration siRNA Targeting Lipoprotein(a)
Professor S. Nissen (Cleveland, US)
Slides Video

Access the full session

Session thumbnail
Beyond statins: the next wave of lipid-lowering therapies
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
New ways to lower low-density lipoprotein cholesterol
28 August 2026
thumbnail
Congress Presentation
VICTORION-Difference study: Inclisiran-based strategy vs standard of care
30 August 2025
thumbnail
Congress Session
HOT LINE 4
30 August 2025
thumbnail
Congress Presentation
Discussant review - VICTORION-Difference
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources